Medlife starts share buyback program
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
The purchase price will be €0.3375 per share, inclusive of dividend, subject to possible adjustments.
The financial results reported at the end of September show total assets of €43.5 million, revenues of €10.6 million, and a net profit of €2.5 million.
The company also seeks the approval of the election of the members of EVERGENT Investments' Board of Directors for a 4-year mandate, as well as the directors' remuneration policy.
The group will offer a maximum of 174,258,721 new shares to investors. The operation starts on June 3, 2024.
Four significant shareholders of One United Properties successfully sold 234,205,285 shares in the Company to local and international institutional investors.
The value of the company increased by 23% in the two years of its presence on the capital market, and at the time of the transfer it had a capitalization of RON 234.7 million.

Romanian PM Ilie Bolojan has announced that a transitional period for natural gas pricing will be implemented between 1 April this year and the end of March 2027.
Mass Global Energy Rom has announced a new strategic investment of approximately €1 billion in Battery Energy Storage System (BESS) capacities.
Star Residence Invest, the first investment platform listed on the Bucharest Stock Exchange (BVB) dedicated to the real estate sector, has appointed Adrian Tănase as CFO.
Romanian grid power operator Transelectrica has signed a Memorandum of Understanding with Georgian State Electrosystem JSC (GSE) to develop the Georgia-Romania Interconnection Project, a submarine cable in the Black Sea.
The Romanian Business Leaders Foundation (RBL) has been accepted as a member of the European Bank for Reconstruction and Development's Civil Society Steering Committee for a two-year mandate from 2026 to 2027.